J Am Coll Cardiol
New ACC guidance calls for tighter postpartum BP control, earlier follow-up
Clinical Takeaway: The new ACC pathway reframes the postpartum period as a high-risk cardiovascular window extending through the first year after delivery, with recommendations for early BP monitoring, rapid follow-up within 7–10 days, aggressive risk-factor screening, and transition to long-term preventive care.
A new 2026 ACC Expert Consensus Decision Pathway emphasizes that cardiovascular care after pregnancy should not stop at hospital discharge, especially for patients with hypertensive disorders of pregnancy, gestational diabetes, obesity, or established cardiovascular disease. The document highlights that more than half of pregnancy-related deaths occur postpartum and calls the postpartum period a “gateway opportunity” to improve lifelong cardiovascular health.
Among the most notable updates is a push for earlier and more proactive blood pressure management. The guidance recommends postpartum BP targets of <140/90 mm Hg before discharge and suggests clinicians consider initiating or intensifying antihypertensive therapy at ≥130/80 mm Hg postpartum — lower than traditional pregnancy thresholds. Remote BP monitoring and telehealth follow-up are strongly encouraged, with evidence cited for reduced readmissions and fewer racial disparities in care.
The pathway also outlines preferred antihypertensive options compatible with lactation, including nifedipine, enalapril, amlodipine, and labetalol, while noting that ACE inhibitors such as enalapril and beta blockers such as metoprolol and carvedilol can generally be continued safely during breastfeeding. Direct oral anticoagulants and several newer heart failure agents still lack robust lactation safety data.
For patients with hypertensive disorders of pregnancy, gestational diabetes, or other adverse pregnancy outcomes, the guidance recommends comprehensive cardiometabolic screening by 6 to 12 weeks postpartum, including lipid testing, diabetes screening, obesity assessment, and long-term ASCVD risk evaluation. The pathway also newly emphasizes adverse pregnancy outcomes as cardiovascular “risk enhancers” that should influence statin and preventive therapy discussions.
The authors also stress that postpartum care must include mental health screening, trauma-informed care, lactation support, contraception counseling, and coordinated transition to primary care and cardiology follow-up.
“Postpartum care optimization begins before birth and continues through the first year after delivery,” the writing committee wrote, adding that “collaborative, patient-centered care is required to reduce maternal morbidity and mortality and to initiate actions toward lifelong cardiovascular health.”
Source: Lindley KJ, et al. (2026, May 22). J Am Coll Cardiol. Optimization of Postpartum Care for Patients With and at Risk for Premature and Long-Term Cardiovascular Disease: 2026 ACC Expert Consensus Decision Pathway: A Report of the American College of Cardiology Solution Set Oversight Committee